EOS Imaging Announces The Opening Of A New EOS Installation At The Prestigious Charité Hospital In Berlin

PARIS--(BUSINESS WIRE)--EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, announced today that the hospital Charité - Universitätsmedizin Berlin in Germany has started to provide patient exams with its new EOS® imaging system. Charité is a leading hospital in Germany with 17 different Charité Centers in the Berlin area.

“Charité is an internationally-recognized institution with a history of providing excellent care. The EOS installation there, adding to earlier installations in key private centers of the country, speaks to the growing recognition in Germany of our technology.”

Established over 300 years ago, Charité is one of the largest university hospitals in Europe. It employs 13,200 employees and handles 142,000 inpatient and 663,000 outpatient cases every year. A leading research institution, Charité lays claim to more than half of all German Nobel Prize winners in Physiology or Medicine.

Professor Dr. Carsten Perka, Medical Director of the Center for Musculoskeletal Surgery at Charité, commented, “The newly-acquired EOS system provides very accurate 3D imaging data for treatment planning. Of particular importance is that the EOS system provides a full-body exam in a functional position while conventional imaging examination positions are often unsuitable for evaluating the musculoskeletal system.”

Marie Meynadier, CEO of EOS imaging, said, “Charité is an internationally-recognized institution with a history of providing excellent care. The EOS installation there, adding to earlier installations in key private centers of the country, speaks to the growing recognition in Germany of our technology.”

For more information, please visit www.eos-imaging.com.

EOS imaging has been chosen to be included in the new EnterNext© PEA-PME 150 index, composed of 150 French companies and listed on Euronext and Alternext markets in Paris.

EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI

About EOS imaging

EOS imaging designs, develops, and markets EOS®, an innovative medical imaging system dedicated to osteoarticular pathologies and orthopedics, as well as associated solutions. The Company is authorized to market in 51 countries, including the United States, Japan, China, and the European Union. The Group posted 2015 revenues of €21.8 million and employs 122 people. The Group is based in Paris and has five subsidiaries in Besançon (France), Cambridge (Massachusetts), Montreal (Canada), Frankfurt (Germany) and Singapore.

Contacts

EOS imaging
Anne Renevot
CFO
+33 (0)1 55 25 61 24
investors@eos-imaging.com
or
NewCap
Financial communication and investor relations
Valentine Brouchot
+33 (0)1 44 71 94 96
eosimaging@newcap.eu
or
The Ruth Group (US)
Press relations / Joanna Zimmerman
646-536-7006
jzimmerman@theruthgroup.com

MORE ON THIS TOPIC